These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15895904)

  • 21. Systemic lupus erythematosus in a patient treated with etanercept for polyarticular juvenile rheumatoid arthritis.
    Bout-Tabaku S; Rivas-Chacon R; Restrepo R
    J Rheumatol; 2007 Dec; 34(12):2503-4. PubMed ID: 18061971
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug-induced systemic lupus erythematosus associated with etanercept therapy in a child with juvenile idiopathic arthritis.
    Lepore L; Marchetti F; Facchini S; Leone V; Ventura A
    Clin Exp Rheumatol; 2003; 21(2):276-7. PubMed ID: 12747299
    [No Abstract]   [Full Text] [Related]  

  • 23. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis.
    Utz JP; Limper AH; Kalra S; Specks U; Scott JP; Vuk-Pavlovic Z; Schroeder DR
    Chest; 2003 Jul; 124(1):177-85. PubMed ID: 12853521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The medical uses and side effects of etanercept with a focus on cutaneous disease.
    Scheinfeld N
    J Drugs Dermatol; 2004; 3(6):653-9. PubMed ID: 15624748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful use of etanercept in the treatment of acute lupus hemophagocytic syndrome.
    Takahashi N; Naniwa T; Banno S
    Mod Rheumatol; 2008; 18(1):72-5. PubMed ID: 18161002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etanercept-Induced Pneumonitis: Severe Complication of Tumor Necrosis Factor-Alpha Blocker Treatment.
    Watad A; Perelman M; Mansour R; Shoenfeld Y; Amital H
    Isr Med Assoc J; 2015 Feb; 17(2):130-2. PubMed ID: 26223096
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic necrotizing pulmonary aspergillosis in a patient treated with a tumor necrosis factor-alpha inhibitor.
    Lee EJ; Song R; Park JN; Lee YA; Son JS; Hong SJ; Yang HI; Lee SH
    Int J Rheum Dis; 2010 Aug; 13(3):e16-9. PubMed ID: 20704604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful Etanercept Treatment for Primary Biliary Cirrhosis Associated with Rheumatoid Arthritis.
    Kovács A; Siminischi AG; Baksay B; Gáll A; Takács M; Szekanecz Z
    Isr Med Assoc J; 2015 Feb; 17(2):114-6. PubMed ID: 26223090
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lupus like syndrome induced by treatment with anti TNFalpha (infliximab): report of three cases].
    Benucci M; Nenci G; Cappelletti C; Manfredi M
    Recenti Prog Med; 2008; 99(7-8):363-6. PubMed ID: 18751615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recall injection-site reactions to etanercept in a patient with psoriasis.
    Papadavid E; Makris M; Dalamaga M; Kalogeromitros D; Stavrianeas N
    Clin Exp Dermatol; 2009 Apr; 34(3):414-5. PubMed ID: 19120391
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cutaneous lupus induced by etanercept in rheumatoid arthritis].
    Abourazzak FE; Guggenbuhl P; Perdriger A; Meadeb J; Gando-Cocley N; Chevrant-Breton J; Hajjaj-Hassouni N; Chalès G
    Rev Med Interne; 2008 Sep; 29(9):744-7. PubMed ID: 18676065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etanercept associated optic neuropathy.
    Chang V; McCurdy D; Gordon LK
    Clin Exp Ophthalmol; 2007; 35(7):680-2. PubMed ID: 17894694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulomatous tattoo reaction in a patient treated with etanercept.
    Bachmeyer C; Blum L; Petitjean B; Kemiche F; Pertuiset E
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):550-2. PubMed ID: 17373994
    [No Abstract]   [Full Text] [Related]  

  • 34. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.
    Mease PJ; Kivitz AJ; Burch FX; Siegel EL; Cohen SB; Ory P; Salonen D; Rubenstein J; Sharp JT; Tsuji W
    Arthritis Rheum; 2004 Jul; 50(7):2264-72. PubMed ID: 15248226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of etanercept in chronic immune-mediated disease.
    Murdaca G; Spanò F; Contatore M; Guastalla A; Magnani O; Puppo F
    Expert Opin Drug Saf; 2014 May; 13(5):649-61. PubMed ID: 24654562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Taiwan experience with etanercept in juvenile rheumatoid arthritis.
    Lai JH
    J Microbiol Immunol Infect; 2005 Dec; 38(6):451-4. PubMed ID: 16341348
    [No Abstract]   [Full Text] [Related]  

  • 37. Etanercept-induced asthma in a psoriatic patient resolving with transition to ustekinumab.
    Torres T; Vilaça S; Velho G; Selores M
    Eur J Dermatol; 2012; 22(5):696-7. PubMed ID: 22910198
    [No Abstract]   [Full Text] [Related]  

  • 38. Etanercept-induced pleuropericardial lupus-like syndrome.
    Porfyridis I; Kalomenidis I; Psallidas I; Stratakos G; Roussos C; Vassilakopoulos T; Stathopoulos GT
    Eur Respir J; 2009 Apr; 33(4):939-41. PubMed ID: 19336597
    [No Abstract]   [Full Text] [Related]  

  • 39. Etanercept: efficacy and safety for approved indications.
    Kerensky TA; Gottlieb AB; Yaniv S; Au SC
    Expert Opin Drug Saf; 2012 Jan; 11(1):121-39. PubMed ID: 22074366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-induced systemic lupus erythematosus and TNF-alpha blockers.
    Ferraccioli GF; Assaloni R; Perin A
    Lancet; 2002 Aug; 360(9333):645; author reply 646. PubMed ID: 12241963
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.